Listen "An Interview With Thomas Holm Pedersen, PhD, Cofounder and CEO of Denmark's NMD Pharma"
Episode Synopsis
Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Thomas Holm Pedersen, PhD, cofounder and chief executive of NMD Pharma, a Danish company that's pursuing the use of chloride channel 1 (ClC-1) as a novel target for restoring muscle function in both myasthenia gravis and spinal muscular atrophy.
More episodes of the podcast Rare Care Podcast
An Interview With Dr. Nicole Lamanna, Leukemia Specialist at Columbia University Medical Center
22/10/2025
An Interview With Dr. May Lee Tjoa, Maternal and Fetal Immunology Expert at Johnson & Johnson
15/10/2025
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.